Registration of securities issued in business combination transactions

Unaudited Condensed Statements of Cash Flows

v3.21.2
Unaudited Condensed Statements of Cash Flows - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:          
Net income (loss) $ 1,013,683 $ (46,399) $ (45,255,407) $ (341) $ (295)
Adjustments to reconcile net income (loss) to net cash used in operating activities:          
Change in fair value of warrant liability (9,232,566) 0 43,139,251 0 0
Issuance costs related to warrant liability     1,075,021 0 0
Change in operating assets and liabilities:          
Decrease in dividend receivable 125 0 (3,883) 0 0
Decrease in prepaid expenses 151,670 0 (599,170) 0 0
Increase in deferred tax assets (513,624) 0 (265,954) 0 0
Increase in accounts payable 7,394,888 46,399 964,734 341 295
Increase in income tax payable 0 0 57 0 0
Net cash used for operating activities (1,185,824) 0 (945,351) 0 0
Cash flows from financing activities:          
Proceeds from Issuance of Common Stock     0 0 5,000
Proceeds from sale of Class A common stock to public     750,000,000 0 0
Proceeds from sale of Private Placement Warrants     17,000,000 0 0
Payment of underwriting discounts     (15,000,000) 0 0
Payment of offering costs (375,000) (225,739) (613,245) 0 0
Proceeds from related party sponsor note 0 300,000      
Proceeds from promissory note     300,000 0 0
Repayment of promissory note     (300,000) 0 0
Proceeds from working capital note 2,000,000 0      
Net cash provided by financing activities 1,625,000 74,261 751,386,755 0 5,000
Increase in cash and restricted cash 439,176 74,261 750,441,404 0 5,000
Cash and restricted cash and cash equivalents at beginning of year 750,446,404 5,000 5,000 5,000 0
Cash and restricted cash and cash equivalents at end of year 750,885,580 79,261 750,446,404 5,000 5,000
Supplemental disclosure of non-cash financing activities          
Accrued offering costs $ 0 $ 692,952 375,000 0 0
Deferred underwriting discount     $ 26,250,000 $ 0 $ 0